-

Tivic Health to Report Second Quarter 2022 Earnings on August 15 Via Conference Call and Webcast

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the second quarter of 2022 via conference call and webcast, Monday, August 15, 2022, at 1:30 pm PT / 4:30 pm ET.

Teleconference Details:
Toll-Free: 877-545-0320
International: 973-528-0002
Participant Access Code: 492379

Webcast Link:
https://www.webcaster4.com/Webcast/Page/2865/46308

Shareholders also may submit questions in advance of the earnings call by sending them to the following email address - ir@tivichealth.com. The deadline for submitting questions in advance of the webcast/conference call is 5:00 PM ET on August 11, 2022. Due to time constraints and the nature of the questions please be advised that not all questions submitted can be answered.

About Tivic Health

Tivic Health Systems, Inc. is a commercial-phase health technology company delivering non-invasive bioelectronic treatments that provide consumers a choice in the treatment of inflammation and related conditions. For more information visit https://tivichealth.com @TivicHealth

Contacts

Investor Contact:
ir@tivichealth.com

Media Contact:
Tivic Health
Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com
617-723-4004

Industry:

Tivic Health Systems, Inc.

NASDAQ:TIVC
Release Versions
English
$Cashtags
$TIVC
Hashtags
#healthcare

Contacts

Investor Contact:
ir@tivichealth.com

Media Contact:
Tivic Health
Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com
617-723-4004

Social Media Profiles
Tivic Health/Facebook
Tivic Health/Instagram
Tivic Health/LinkedIn
More News From Tivic Health Systems, Inc.

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its year-end financial results for 2024 via pre-recorded conference call and webcast on Friday, March 21, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID...

Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today new data that shows personalizing its non-invasive vagus nerve stimulation (ncVNS) method optimized the stimulation’s impact on autonomic nervous system activity. Tivic Health believes these findings strongly support its strategy to develop highly personalized neuromodulation devices that can better address inflammatory, cardiac and neurologic disorders compared to c...

Tivic Health Systems, Inc. Announces Reverse Stock Split

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic Health” or the “Company), a diversified therapeutics company, announced today that its Board of Directors has declared a 1-for-17 reverse stock split of the Company’s issued and outstanding shares of common stock. The purpose of the reverse stock split is to bring the Company into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market (“Nasdaq”), and is part of the...
Back to Newsroom